Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7076 | 1332 | 29.1 | 64% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
288 | 18308 | SEROTONIN//5 HT1A RECEPTOR//5 HT1A RECEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SARPOGRELATE | Author keyword | 86 | 77% | 4% | 59 |
2 | SARPOGRELATE HYDROCHLORIDE | Author keyword | 13 | 69% | 1% | 11 |
3 | KETANSERIN | Author keyword | 11 | 15% | 5% | 67 |
4 | AT 1015 | Author keyword | 8 | 100% | 0% | 5 |
5 | NEXOPAMIL | Author keyword | 6 | 80% | 0% | 4 |
6 | MCI 9042 | Author keyword | 6 | 71% | 0% | 5 |
7 | R 102444 | Author keyword | 4 | 75% | 0% | 3 |
8 | DV 7028 | Author keyword | 3 | 60% | 0% | 3 |
9 | ICI 170 809 | Author keyword | 3 | 60% | 0% | 3 |
10 | EXPERIMENTAL ARTERIAL THROMBOSIS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SARPOGRELATE | 86 | 77% | 4% | 59 | Search SARPOGRELATE | Search SARPOGRELATE |
2 | SARPOGRELATE HYDROCHLORIDE | 13 | 69% | 1% | 11 | Search SARPOGRELATE+HYDROCHLORIDE | Search SARPOGRELATE+HYDROCHLORIDE |
3 | KETANSERIN | 11 | 15% | 5% | 67 | Search KETANSERIN | Search KETANSERIN |
4 | AT 1015 | 8 | 100% | 0% | 5 | Search AT+1015 | Search AT+1015 |
5 | NEXOPAMIL | 6 | 80% | 0% | 4 | Search NEXOPAMIL | Search NEXOPAMIL |
6 | MCI 9042 | 6 | 71% | 0% | 5 | Search MCI+9042 | Search MCI+9042 |
7 | R 102444 | 4 | 75% | 0% | 3 | Search R+102444 | Search R+102444 |
8 | DV 7028 | 3 | 60% | 0% | 3 | Search DV+7028 | Search DV+7028 |
9 | ICI 170 809 | 3 | 60% | 0% | 3 | Search ICI+170+809 | Search ICI+170+809 |
10 | EXPERIMENTAL ARTERIAL THROMBOSIS | 2 | 67% | 0% | 2 | Search EXPERIMENTAL+ARTERIAL+THROMBOSIS | Search EXPERIMENTAL+ARTERIAL+THROMBOSIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MCI 9042 | 30 | 79% | 1% | 19 |
2 | KETANSERIN | 21 | 24% | 6% | 76 |
3 | SARPOGRELATE | 18 | 59% | 2% | 20 |
4 | SEROTONIN ANTAGONISTS | 10 | 54% | 1% | 13 |
5 | CYCLIC FLOW VARIATIONS | 10 | 26% | 2% | 31 |
6 | R 41 468 | 10 | 52% | 1% | 13 |
7 | LY53857 | 8 | 75% | 0% | 6 |
8 | INCREASES CIRCULATING ADIPONECTIN | 8 | 100% | 0% | 5 |
9 | KETANSERIN R 41 468 | 7 | 43% | 1% | 12 |
10 | ANTIPLATELET AGENT | 6 | 23% | 2% | 23 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
SEROTONIN AND SEROTONIN ANTAGONISM IN CARDIOVASCULAR AND NON-CARDIOVASCULAR DISEASE | 1995 | 65 | 158 | 80% |
Serotonin and the heart | 2000 | 66 | 115 | 70% |
SEROTONINERGIC MECHANISMS IN HYPERTENSION - FOCUS ON THE EFFECTS OF KETANSERIN | 1988 | 97 | 216 | 78% |
KETANSERIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN HYPERTENSION AND PERIPHERAL VASCULAR-DISEASE | 1990 | 53 | 232 | 73% |
The love of a lifetime: 5-HT in the cardiovascular system | 2009 | 10 | 28 | 68% |
5-HT in systemic hypertension: foe, friend or fantasy? | 2005 | 48 | 121 | 38% |
Effect of sarpogrelate on cardiovascular disorders | 2011 | 2 | 8 | 88% |
5-Hydroxtryptamine Receptors in Systemic Hypertension: An Arterial Focus | 2011 | 11 | 119 | 34% |
Therapeutic potentials of sarpogrelate in cardiovascular disease | 2004 | 37 | 136 | 50% |
Functions of 5-HT2A receptor and its antagonists in the cardiovascular system | 2004 | 88 | 202 | 23% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DR MOLEWATERPLEIN 40 | 1 | 50% | 0.1% | 1 |
2 | U715 | 1 | 50% | 0.1% | 1 |
3 | NEPHROL INTERNAL DIS | 1 | 29% | 0.2% | 2 |
4 | ST BONI E GEN HOSP CARDIOVASC SCI | 1 | 16% | 0.2% | 3 |
5 | S PHARMACOL | 1 | 22% | 0.2% | 2 |
6 | EXCELLENCEAOBA KU | 0 | 33% | 0.1% | 1 |
7 | FED PUBL SERV PERSONNEL MUTUAL AID ASSOC | 0 | 33% | 0.1% | 1 |
8 | HLTH SCI SW MED PHARMACOL | 0 | 33% | 0.1% | 1 |
9 | LCG BIOSCI | 0 | 33% | 0.1% | 1 |
10 | MITOCHONDRIAL GRP 1 | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000174692 | 5 HT1D RECEPTOR//GR127935//5 HT MODULINE |
2 | 0.0000147155 | URAPIDIL//PHARMACOLOGY URAPIDIL//ANESTHETIZED CATS |
3 | 0.0000112563 | NAFTIDROFURYL//NEBRACETAM//MICROSPHERE EMBOLISM |
4 | 0.0000064200 | 5 HT2C RECEPTOR//5 HT2C RECEPTORS//5 HT2A RECEPTOR |
5 | 0.0000058021 | BLEEDING ABNORMALITIES//VENOUS THROMBOSIS AND EMBOLISM//ABORATING TRAINING PHARMACOEPIDEMIO |
6 | 0.0000052107 | 5HT3A//NUTR CELLULAIRE METAB//UNITE IMMUNOPHYSIOL GEN COMPAREE |
7 | 0.0000049344 | CARANE DERIVATIVES//AII RECEPTORS//BLOOD PLATELET |
8 | 0.0000049161 | TRANSGENES CARDIOVASC CONTROL//SILICONE COLLAR//WHHL RABBIT |
9 | 0.0000042659 | BUILDUP PROCESS//DELTA OPIATE RECEPTORS//DNA INTERACTION AND FRAGMENTATION |
10 | 0.0000041803 | H 3 IMIPRAMINE BINDING//IMIPRAMINE BINDING//H 3PAROXETINE BINDING |